Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sqz Biotechnologies Company (NY: SQZ )

0.8300 +0.0100 (+1.22%)
Official Closing Price Updated: 4:10 PM EST, Jan 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 120,596
Open 0.8300
Bid (Size) 0.8100 (3)
Ask (Size) 0.8396 (10)
Prev. Close 0.8200
Today's Range 0.8100 - 0.8774
52wk Range 0.6538 - 8.207
Shares Outstanding 29,450,616
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
SQZ Biotechnologies Receives Notice Regarding Continued Listing Standards From the New York Stock Exchange
From SQZ Biotechnologies
Via Business Wire
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 258 companies hit new 52-week lows. 
Via Benzinga

Performance

YTD
+12.16%
+12.16%
1 Month
+12.16%
+12.16%
3 Month
-70.88%
-70.88%
6 Month
-69.60%
-69.60%
1 Year
-89.65%
-89.65%

More News

Read More
SQZ Biotechnologies's Return On Capital Employed Overview
Via Benzinga
Expert Ratings for SQZ Biotechnologies
Via Benzinga
Analyst Ratings for SQZ Biotechnologies
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
NYSE:SQZ Investor Notice: Investigation over Possible Securities Laws Violations by SQZ Biotechnologies Company
Via SBWire
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
SQZ Biotechnologies Receives FDA Fast Track Designation for its eAPC Therapeutic Candidate for Treatment of HPV16+ Tumors and Presents Clinical Data for Multiple Programs at the European Society for Medical Oncology Immuno-Oncology Congress
From SQZ Biotechnologies Company
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 2, 2022
Via Benzinga
US Stocks Mixed After Wednesday's Rally
Via Benzinga
SQZ Biotechnologies Announces Strategic Prioritization of SQZ® Enhanced Antigen Presenting Cells Program; Armon Sharei to Step Down as Chief Executive Officer
From SQZ Biotechnologies
Via Business Wire
Why Dollar General Shares Are Trading Lower By Over 8%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
SQZ Biotechnologies Presents Cell Squeeze® Manufacturing Platform, Linked Antigen mRNA Preclinical Research, and COMMANDER-001 Phase 1/2 Clinical Trial in Progress Poster at Society for Immunotherapy of Cancer Annual Meeting
From SQZ Biotechnologies
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022
Via Benzinga
SQZ Biotechnologies Reports Third Quarter 2022 Financial Results and Recent Portfolio Updates
From SQZ Biotechnologies
Via Business Wire
Analyst Bullish On SQZ Biotech's Technology For Solving Cell Therapy Challenges
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2022
Via Benzinga
SQZ Biotechnologies Publishes Preclinical Research Demonstrating SQZ® AAC Platform’s Potential as an Effective Red Blood Cell-Derived Immunotherapy
From SQZ Biotechnologies Company
Via Business Wire
SQZ Biotechnologies Presents Preclinical SQZ® TIL Data Supporting Potential Ability of mRNA-Driven IL-2 and IL-12 Expression to Eliminate Need for Toxic Preconditioning and Systemic IL-2 Administration for Certain T Cell Therapies
From SQZ Biotechnologies Company
Via Business Wire
SQZ Biotechnologies to Present at Upcoming Investor Conferences
From SQZ Biotechnologies Company
Via Business Wire
SQZ Biotechnologies Announces Leadership Transition
From SQZ Biotechnologies Company
Via Business Wire
SQZ Biotechnologies Reports Second Quarter 2022 Financial Results and Recent Portfolio Updates
From SQZ Biotechnologies
Via Business Wire
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.